Health & Biotech ASX Health: 4D Medical jumps 16pc on lungs device rollout, Proteomics up 10pc on UK deal November 23, 2021 The ASX 200 Health Index (XHJ) is down by 0.30% at the time of writing, compared to the broader index… Paul Hopper on whether his new venture Radiopharm Theranostics will be a takeover target, and the keys to biotech success November 23, 2021 Paul Hopper, the man behind Viralytics, Imugene (ASX:IMU) and Chimeric Therapeutics (ASX:CHM), is about to launch another biotech venture -… ASX Health: Twiggy Forrest’s investment fund takes a stake in this ASX cannabis stock November 22, 2021 The ASX 200 Health Index (XHJ) is down by 0.35% at the time of writing, compared to the broader index… Prescient bolsters board with experienced and leading figures in CAR-T therapy November 19, 2021 The new appointments will support Prescient’s ongoing and novel development of its Omnicar CAR-T therapy. Clinical stage oncology company Prescient… ScoPo’s Powerplays: Investors look to Healthcare for ESG exposure, and Volpara is the poster child November 19, 2021 Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains… Apiam expands presence in national animal health market with Equine Clinic acquisition November 19, 2021 Special Report: The Agnes Bank clinic in NSW will help cornerstone Apiam’s broader strategic push into equine services in regional… ASX Health Stocks: Apiam and Trajan on acquisition trail, Immutep provides updates on Phase 2 trials November 19, 2021 The ASX 200 Health Index (XHJ) is up by 0.80% at the time of writing, compared to the broader index… Stock Insiders: InteliCare smart sensor and AI technology is assisting care providers and their families November 19, 2021 Stock Insiders is a new podcast series focussed on investing hosted by renowned business journalist Oriel Morrison. The program is sponsored by Barclay… PharmAust marches ahead to Phase 1 trials on COVID-19 and motor neurone disease November 17, 2021 Special Report: The Phase 1 human clinical trials of monepantel (MPL) for the treatment of COVID-19 and motor neurone disease… ASX Health Stocks: Amplia eyes human trials for pancreatic cancer drug November 17, 2021 Amplia targets human trials for pancreatic cancer drug Noxopharm subsidiary enters licence agreement with Hudson Insitiute of Medical Research $7.2… Next» « Previous